André Rogatko

Available identifiers

Publication	Date of Publication	Type
Dose finding with escalation with overdose control (EWOC) in cancer clinical trials	2016-01-05	Paper
Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials	2013-01-09	Paper
Number of patients per cohort and sample size considerations using dose escalation with overdose control	2013-01-09	Paper
Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control	2012-10-10	Paper
https://portal.mardi4nfdi.de/entity/Q3010726	2011-06-27	Paper
https://portal.mardi4nfdi.de/entity/Q3622500	2009-04-28	Paper
A NEUTROSOPHIC DESCRIPTION LOGIC	2009-01-28	Paper
Hardy-Weinberg equilibrium diagnostics	2006-10-31	Paper
https://portal.mardi4nfdi.de/entity/Q3374155	2006-03-09	Paper
Statistical assessment of multivalued screening tests	2001-07-03	Paper
https://portal.mardi4nfdi.de/entity/Q4246937	1999-10-17	Paper
Optimal Bayesian-feasible dose escalation for cancer phase I trials	1999-01-06	Paper
https://portal.mardi4nfdi.de/entity/Q4367812	1998-09-27	Paper
Bayesian approach for meta - analysis of controlled clinical trials	1993-10-11	Paper
A General Theory of Prediction in Finite Populations	1985-01-01	Paper

No records found.

Property	Value
MaRDI profile type	MaRDI person profile
instance of	human

This page was built for person: André Rogatko